Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha Omega Trial: A Randomised, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients With a History of Myocardial Infarction

NCT00127452 is registered in ClinicalTrials.gov with Wageningen University as lead sponsor.

NCT NCT00127452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00127452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha Omega Trial: A Randomised, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients With a History of Myocardial Infarction
Lead sponsor
Wageningen University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2002
Completion date
June 30, 2010
Enrollment
4,837 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases